?
Anderson
2016 Neurology
? ICUs
3310 patients
Acute ischaemic stroke: low vs standard dose alteplase
Clinical Question
In patients with acute ischaemic stroke, is low-dose thrombolysis therapy
with intravenous alteplase non-inferior to standard-dose therapy with
respect to death and disability at 90 days?
Critical Appraisal
- Population
- Not recorded
- Population Details
- Not recorded
- Intervention Arms
- Not recorded
- Control Arms
- Not recorded
- Primary Outcome
- Not recorded
- Secondary Outcomes
- Not recorded
- P Value
- Not recorded
Outcome Results
Not recorded